Four drugs or medical devices approved by the FDA since April 1:
1. Evenity, a monthly injection, is approved to treat osteoporosis is postmenopausal women at high risk of bone fracture.
2. Dovato is a two-drug, fixed-dose complete regimen for HIV patients who have not received antiretroviral treatment.
3. The FDA expanded indication of Ibrance, a metastatic breast cancer treatment, to include male patients.
4. The FDA expanded the label for Keytruda, a cancer immunotherapy drug, as monotherapy for the first-line treatment of patients with stage 3 non-small cell lung cancer who are not able to receive surgical resection of chemoradiation.